OS5.1 Phase I clinical trial with oncolytic virus DNX-2401 for DIPGs

Authors: M M Alonso, I Iñigo, M Gonzalez-Huarriz, P Dominguez, A Patiño, C Jones, C Gomez-Manzano, J Fueyo, R Díez-Valle, S Tejada

Published: 2019-09-06

DOI: 10.1093/neuonc/noz126.035

Source: Full article


Abstract

Abstract